A Phase 4 Study to Evaluate Response to Treatment and Safety of Paliperidone Extended-Release in Participants With Schizophrenia

NCT00915512 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Paliperidone extended-release (ER)

Sponsor

Janssen-Cilag Turkey